Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$549M |
| 2 |
Procter & Gamble
PG
|
+$422M |
| 3 |
Merck
MRK
|
+$374M |
| 4 |
Amazon
AMZN
|
+$345M |
| 5 |
Hasbro
HAS
|
+$309M |
Top Sells
| 1 |
Walt Disney
DIS
|
+$475M |
| 2 |
CELG
Celgene Corp
CELG
|
+$415M |
| 3 |
Mastercard
MA
|
+$322M |
| 4 |
Intuitive Surgical
ISRG
|
+$320M |
| 5 |
PayPal
PYPL
|
+$285M |
Sector Composition
| 1 | Technology | 26.63% |
| 2 | Healthcare | 17.13% |
| 3 | Financials | 11.91% |
| 4 | Industrials | 10.85% |
| 5 | Consumer Discretionary | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Heron Therapeutics
HRTX
$199M
| $116M | 0.06% |
4,915,313
-214,028
| -4% | -$5.03M |
|
327
BWX Technologies
BWXT
$14.8B
| $115M | 0.06% |
1,858,932
-6,845
| -0.4% | -$425K |
|
328
Vistra
VST
$65.7B
| $115M | 0.06% |
5,005,039
-303,865
| -6% | -$6.99M |
|
329
Starbucks
SBUX
$95.3B
| $115M | 0.06% |
1,305,937
-630,172
| -33% | -$55.4M |
|
330
Unifirst Corp
UNF
$3.21B
| $115M | 0.06% |
568,111
-42,474
| -7% | -$8.58M |
|
331
Kellanova
K
$27.6B
| $114M | 0.06% |
1,755,858
+55,649
| +3% | +$3.61M |
|
332
Trinity Industries
TRN
$2.28B
| $114M | 0.06% |
5,134,250
+1,295,814
| +34% | +$28.7M |
|
333
Waste Connections
WCN
$45.7B
| $114M | 0.06% |
1,251,648
-335,841
| -21% | -$30.5M |
|
334
Moody's
MCO
$91.1B
| $113M | 0.06% |
477,739
-73,767
| -13% | -$17.5M |
|
335
FibroGen
FGEN
$46.4M
| $113M | 0.06% |
105,588
-1,304
| -1% | -$1.4M |
|
|
CHX
336
DELISTED
ChampionX
CHX
| $113M | 0.06% |
3,349,380
+267,737
| +9% | +$9.04M |
|
337
Trimble
TRMB
$19.1B
| $113M | 0.06% |
2,703,027
+345,931
| +15% | +$14.4M |
|
338
Lamb Weston
LW
$7.96B
| $111M | 0.06% |
1,288,332
-388,380
| -23% | -$33.4M |
|
339
Ironwood Pharmaceuticals
IRWD
$180M
| $110M | 0.06% |
8,289,895
+888,863
| +12% | +$11.8M |
|
340
BridgeBio Pharma
BBIO
$10.2B
| $110M | 0.06% |
3,141,081
+2,688,910
| +595% | +$94.2M |
|
341
Fox Class B
FOX
$23.6B
| $110M | 0.06% |
3,024,286
+192,903
| +7% | +$7.02M |
|
342
Valero Energy
VLO
$50.3B
| $109M | 0.06% |
1,168,804
-897,019
| -43% | -$84M |
|
343
HCA Healthcare
HCA
$96.7B
| $109M | 0.06% |
739,827
-637,987
| -46% | -$94.3M |
|
344
Marriott International Class A Common Stock
MAR
$71.7B
| $109M | 0.06% |
719,002
-374,219
| -34% | -$56.7M |
|
|
EGRX
345
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $108M | 0.06% |
1,799,709
+33,909
| +2% | +$2.04M |
|
346
Prologis
PLD
$104B
| $108M | 0.06% |
1,211,684
-7,226
| -0.6% | -$644K |
|
347
GATX Corp
GATX
$5.99B
| $108M | 0.06% |
1,299,026
+850
| +0.1% | +$70.4K |
|
348
LendingTree
TREE
$988M
| $108M | 0.06% |
354,672
-9,982
| -3% | -$3.03M |
|
|
VMW
349
DELISTED
VMware, Inc
VMW
| $107M | 0.05% |
705,925
+206,157
| +41% | +$31.3M |
|
350
Magnolia Oil & Gas
MGY
$4.32B
| $107M | 0.05% |
8,491,415
+1,186
| +0% | +$14.9K |
|